昭衍新药(06127)：昭衍(苏州)新药认购工商银行合共4000万元理财产品

Group 1 - The company, Zhaoyan New Drug (06127), announced an agreement with Industrial and Commercial Bank of China to subscribe to two wealth management products totaling RMB 40 million [1] - The total investment amount in these wealth management products, including those not yet redeemed as of the announcement date, is RMB 410 million [1]